# Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

> **NCT02140242** · PHASE3 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 721 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **DRUG:** study part 1 - dose daunorubicin
- **PROCEDURE:** induction cycles

## Key facts

- **NCT ID:** NCT02140242
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-16
- **Primary completion:** 2022-04-25
- **Final completion:** 2022-04-25
- **Target enrollment:** 721 (ACTUAL)
- **Last updated:** 2023-09-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140242, "Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02140242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*